Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Third-generation beta1/alpha-adrenoceptor blocker with hypotensive and bradycardic effects

July 31, 2002

Enrollment complete in tecadenoson phase III trial

July 31, 2002

Novel Na+/HCO3- cotransporter inhibitors described in recent patent

July 30, 2002

Aventis claims novel antiarrhythmic Kv1.5 channel blockers

July 30, 2002

Vita launches Eneas in Spain

July 29, 2002

Oral formulation of YM-087 dropped from development

July 26, 2002

PPARgamma ligand protects heart from reperfusion injury

July 26, 2002

PST-2744 tested in cardiomyopathic hamster model of heart failure

July 26, 2002

KRN-4884 mimics effects of hypoxic preconditioning in coronary preparations

July 26, 2002

GLI-5021: a novel therapeutic for acute and chronic myocardial ischemia

July 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...